BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8737645)

  • 1. Proband and parent assistance in identifying relatives for cystic fibrosis carrier testing.
    Sorenson JR; Cheuvront B; Bruning A; Talton S; DeVellis B; Koch G; Callanan N; Fernald G
    Am J Med Genet; 1996 Jun; 63(3):419-25. PubMed ID: 8737645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients.
    Sorenson JR; Cheuvront B; DeVellis B; Callanan N; Silverman L; Koch G; Sharp T; Fernald G
    Am J Med Genet; 1997 May; 70(2):121-9. PubMed ID: 9128929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives.
    Cheuvront B; Sorensen JR; Callanan NP; Stearns SC; DeVellis BM
    Am J Med Genet; 1998 Feb; 75(5):461-8. PubMed ID: 9489788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis.
    Denayer L; Evers-Kiebooms G; De Boeck K; Van den Berghe H
    Am J Med Genet; 1992 Sep; 44(1):104-11. PubMed ID: 1519639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to carrier testing for adult cystic fibrosis sibs: the importance of not knowing.
    Fanos JH; Johnson JP
    Am J Med Genet; 1995 Oct; 59(1):85-91. PubMed ID: 8849018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of family history on disclosure patterns of cystic fibrosis carrier status.
    Ormond KE; Mills PL; Lester LA; Ross LF
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):70-7. PubMed ID: 12704640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
    Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in psychosocial reactions to cystic fibrosis carrier testing.
    Newman JE; Sorenson JR; DeVellis BM; Cheuvront B
    Am J Med Genet; 2002 Nov; 113(2):151-7. PubMed ID: 12407705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S; Curnow L; Ross M; Massie J
    J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade carrier-testing in cystic fibrosis.
    Roberts T; Schwarz MJ; Kerr-Liddell R; Hinks JL; Super M
    Paediatr Respir Rev; 2003 Dec; 4(4):293-8. PubMed ID: 14629951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
    Mussaffi H; Prais D; Mei-Zahav M; Blau H
    Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA analysis of cystic fibrosis genotypes in relatives with equivocal sweat test results.
    Amos JA; Janes SR; Erbe RW
    Clin Invest Med; 1990 Feb; 13(1):1-5. PubMed ID: 2311311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The views of general practitioners on community carrier screening for cystic fibrosis.
    Boulton M; Cummings C; Williamson R
    Br J Gen Pract; 1996 May; 46(406):299-301. PubMed ID: 8762747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A; Koscik RL; Farrell PM; Rock MJ
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation.
    Wang X; Kim J; McWilliams R; Cutting GR
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):237-40. PubMed ID: 15781764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweat electrolyte and cystic fibrosis mutation analysis allows early diagnosis in Brazilian children with clinical signs compatible with cystic fibrosis.
    Rabbi-Bortolini E; Bernardino AL; Lopes AL; Ferri AS; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Apr; 76(4):288-90. PubMed ID: 9545091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families.
    Henneman L; Kooij L; Bouman K; ten Kate LP
    Am J Med Genet; 2002 Jul; 110(4):324-31. PubMed ID: 12116205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.
    McClaren BJ; Metcalfe SA; Aitken M; Massie RJ; Ukoumunne OC; Amor DJ
    Eur J Hum Genet; 2010 Oct; 18(10):1084-9. PubMed ID: 20512163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.